QRxPharma Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:QRxPharma Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12325
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
QRxPharma Ltd (QRxPharma) develops and commercializes treatments for pain management and abuse prevention products. The company’s product portfolio includes late and early stage clinical drug candidates. Its dual opioid product portfolio includes Moxduo IR (Q8003), an immediate release oral capsule for the treatment of acute management of moderate to severe pain; Moxduo IV (Q8012), an intravenous formulation for moderate to severe hospital-based pain; and Moxduo CR (Q8011), a controlled release oral tablet being developed in Phase II clinical trial for the treatment of chronic pain. The company’s abuse deterrent technology called Stealth Beadlets has been developed for controlled release Moxduo formulation. It has operations in the US and Australia. QRxPharma is headquartered in North Sydney, New South Wales, Australia.

QRxPharma Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
QRxPharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
QRxPharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
QRxPharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
QRxPharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
QRxPharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
QRxPharma Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
QrxPharma Enters Into Agreement With Aesica Formulation For Stealth Beadlets Abuse Deterrence Technology 10
Licensing Agreements 11
QRxPharma Enters Into Licensing Agreement With Teva Pharma For Moxduo 11
QRxPharma Enters Into Licensing Agreement With Aspen Pharma For Moxduo 13
QRxPharma Exercises Option For Licensing Agreement With Aspen Pharma For Moxduo 14
QrxPharma Enters Into Licensing Agreement With Paladin Labs For Moxduo 15
QrxPharma Enters Into Licensing Agreement With Actavis For MoxDuo IR 17
Equity Offering 19
QRxPharma Completes Rights Offering Of Shares For US$3.8 Million 19
QRxPharma Completes Private Placement Of Shares For US$7 Million 21
QRxPharma Ltd – Key Competitors 23
QRxPharma Ltd – Key Employees 24
QRxPharma Ltd – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Joint Venture 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
QRxPharma Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
QRxPharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
QRxPharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
QRxPharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
QRxPharma Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
QRxPharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
QrxPharma Enters Into Agreement With Aesica Formulation For Stealth Beadlets Abuse Deterrence Technology 10
QRxPharma Enters Into Licensing Agreement With Teva Pharma For Moxduo 11
QRxPharma Enters Into Licensing Agreement With Aspen Pharma For Moxduo 13
QRxPharma Exercises Option For Licensing Agreement With Aspen Pharma For Moxduo 14
QrxPharma Enters Into Licensing Agreement With Paladin Labs For Moxduo 15
QrxPharma Enters Into Licensing Agreement With Actavis For MoxDuo IR 17
QRxPharma Completes Rights Offering Of Shares For US$3.8 Million 19
QRxPharma Completes Private Placement Of Shares For US$7 Million 21
QRxPharma Ltd, Key Competitors 23
QRxPharma Ltd, Key Employees 24
QRxPharma Ltd, Subsidiaries 25
QRxPharma Ltd, Joint Venture 25

List of Figures
QRxPharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
QRxPharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
QRxPharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
QRxPharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
QRxPharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
QRxPharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
QRxPharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
QRxPharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[QRxPharma Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BorgWarner Inc (BWA):企業の財務・戦略的SWOT分析
    BorgWarner Inc (BWA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • MSIG Holdings (Asia) Pte. Ltd.:企業の戦略・SWOT・財務情報
    MSIG Holdings (Asia) Pte. Ltd. - Strategy, SWOT and Corporate Finance Report Summary MSIG Holdings (Asia) Pte. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • EVN AG (EVN):企業の財務・戦略的SWOT分析
    EVN AG (EVN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Skanska AB:企業の戦略・SWOT・財務分析
    Skanska AB - Strategy, SWOT and Corporate Finance Report Summary Skanska AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Glori Energy Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Glori Energy Inc (Glori Energy) is an energy technology and an oil production company. The company deploys proprietary technology to increase the amount of oil that can be produced from conventional oil fields which it marketed to third party exploration and production companies. It also own …
  • Genting Malaysia Berhad:企業の戦略・SWOT・財務情報
    Genting Malaysia Berhad - Strategy, SWOT and Corporate Finance Report Summary Genting Malaysia Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Pt Mandom Indonesia Tbk:企業の戦略・SWOT・財務情報
    Pt Mandom Indonesia Tbk - Strategy, SWOT and Corporate Finance Report Summary Pt Mandom Indonesia Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • AptarGroup Inc:企業の戦略・SWOT・財務情報
    AptarGroup Inc - Strategy, SWOT and Corporate Finance Report Summary AptarGroup Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • TriGranit Corporation:企業の戦略・SWOT・財務情報
    TriGranit Corporation - Strategy, SWOT and Corporate Finance Report Summary TriGranit Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • South Broward Hospital District:企業の戦略的SWOT分析
    South Broward Hospital District - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Capio AB:企業の戦略・SWOT・財務情報
    Capio AB - Strategy, SWOT and Corporate Finance Report Summary Capio AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • George Weston Limited:企業の戦略・SWOT・財務情報
    George Weston Limited - Strategy, SWOT and Corporate Finance Report Summary George Weston Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Mars, Incorporated:企業の戦略・SWOT・財務情報
    Mars, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Mars, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Housing Development Finance Corporation Ltd:企業のM&A・事業提携・投資動向
    Housing Development Finance Corporation Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Housing Development Finance Corporation Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, det …
  • Oge Energy Corp:企業の戦略・SWOT・財務分析
    Oge Energy Corp - Strategy, SWOT and Corporate Finance Report Summary Oge Energy Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Exmar NV (EXM):石油・ガス:M&Aディール及び事業提携情報
    Summary Exmar NV (Exmar), a subsidiary of Compagnie Maritime Belge SA, is a shipping and energy supply chain solutions provider. The company operates through four segments liquefied natural gas (LNG), offshore, liquid petroleum gas (LPG) and services. Its LNG segment offers floating liquefaction, fl …
  • Joslin Diabetes Center:製薬・医療:M&Aディール及び事業提携情報
    Summary Joslin Diabetes Center (Joslin) is a healthcare service provider that offers diabetes treatment, research and education services. The center provides services such as weight management programs, pregnancy program, eye care, diabetes prevention, research, diabetes patient education, adult dia …
  • NuGEN Technologies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary NuGEN Technologies Inc (NuGEN) is a provider of biological science reagents. The company provides DNA and RNA sample preparation products for use in research and diagnostic applications. Its products include Next-Gen Sequencing applications, which include RNA-Seq, targeted resequencing of DN …
  • Boone Electric Cooperative:企業の戦略的SWOT分析
    Boone Electric Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Patterson-UTI Energy, Inc. (PTEN):石油・ガス:M&Aディール及び事業提携情報
    Summary Patterson-UTI Energy Inc (Patterson) is an oilfield service provider. It offers onshore contract drilling and pressure pumping services to oil and gas exploration and production companies. The company offers pressure pumping services such as well stimulation and cementing for completion of n …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆